Kei Tsuzurahara
Kei Tsuzurahara publishes mostly in Organic Chemistry, Molecular Biology and Immunology, on topics such as Synthesis and biological activity, Asthma and respiratory diseases and Quinazolinone synthesis and applications.
- World rank
- #7,382,684 of 7,710,434 ranked researchers
- Rank in United States
- #1,605,030 of 1,627,098
- Works
- 30
- Citations
- 124
- Citations per work
- 4.1
What does Kei Tsuzurahara research?
Kei Tsuzurahara's work is mostly in Chemistry (26%), Medicine (23%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else827.9%
- Physical Sciences825.6%
- Chemistry825.6%
- Health Sciences723.3%
- Medicine723.3%
- Life Sciences723.2%
- 1Organic Chemistry26% of their works
- 2Molecular Biology12% of their works
- 3Immunology11% of their works
- 4Pharmacology10% of their works
- 5Physiology10% of their works
- 6Genetics4% of their works
Research topics
- Synthesis and biological activity
- Asthma and respiratory diseases
- Quinazolinone synthesis and applications
- Synthesis of Tetrazole Derivatives
- Mast cells and histamine
- Synthesis and Characterization of Heterocyclic Compounds
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Drug-Induced Adverse Reactions
Which keywords describe Kei Tsuzurahara's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Synthesis, Inflammation, Heterocyclic Compounds, Tubulin Inhibitors, Allergic Diseases and Anticancer.
- Stevens-Johnson Syndrome
- Kinin Receptor Family
- HLA-B*5701
- Allergic Disease
- Quinazoline
- Catalysis
- Asthma
- Anticancer
- Tubulin Inhibitors
- Inflammation
- Medicinal Chemistry
- Anticancer Agents
- Synthesis
- Heterocyclic Compounds
- Allergic Diseases
- Antimicrobial
- Heterocycles
- Indirubin
- Tetrazoles
- Drug Discovery
- Hereditary Angioedema
- Mast Cells
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Anticancer Agents122 topics
- Medicinal Chemistry122 topics
- Synthesis113 topics
- Inflammation102 topics
- Heterocyclic Compounds81 topic
- Tubulin Inhibitors81 topic
- Allergic Diseases71 topic
- Anticancer72 topics
- Antimicrobial72 topics
- Asthma71 topic
- Heterocycles72 topics
- Catalysis41 topic
- Indirubin41 topic
- Quinazoline41 topic
- Tetrazoles41 topic
- Allergic Disease31 topic
- Drug Discovery31 topic
- HLA-B*570131 topic
- Hereditary Angioedema31 topic
- Kinin Receptor Family31 topic
- Mast Cells31 topic
- Stevens-Johnson Syndrome31 topic
- Triazines31 topic
Where does Kei Tsuzurahara work?
Kei Tsuzurahara's main affiliation in the publication record is Tanabe Research Laboratories, United States.
How many publications and citations does Kei Tsuzurahara have?
OpenAlex counts 30 works and 124 citations for Kei Tsuzurahara, an h-index of 6, ranking #7,382,684 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kei Tsuzurahara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.